Diagnosis and management of multiple myeloma.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004334:Drug Administration Schedule; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007372:Interferons / Q000627:therapeutic use; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D016522:Oncology Service, Hospital; D010347:Patient Care Planning / Q000592:standards; D010353:Patient Education as Topic; D018579:Patient Selection; D011239:Prednisolone / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000150:complications / Q000628:therapy
D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D004164:Diphosphonates; D003520:Cyclophosphamide; D007372:Interferons; D011239:Prednisolone; D008558:Melphalan